News

Irenas of the United States District Court for the District of New Jersey in the patent infringement lawsuit filed by Horizon against Watson Laboratories, Inc. for an Abbreviated

Severe aplastic anaemia is a rare disorder in which the bone marrow fails to make enough new blood cells. Currently, there are no approved therapies available for SAA

Following approval for the IND application, the company will conduct a Phase I/II trial of ADXS-HPV alone or in combination with MedImmune’s investigational anti-PD-L1 immune checkpoint inhibitor, MEDI4736,

Ophthotech now has exclusive license to investigate the potential of AVEO’s tivozanib, outside of Asia for the potential treatment of non-oncologic diseases of the eye. As part of

Currently, the company is conducting an international, randomized Phase III trial of TH-302 in these patients in partnership with the Sarcoma Alliance for Research through Collaboration (SARC) and

The NIH Proteus syndrome team is led by researchers who originally discovered the somatic single (point) mutation in the AKT 1 oncogene that causes Proteus syndrome. On that

In the initial phase of the clinical program scheduled to commence this month, eight (8) DKD patients will be enrolled. The objectives of this double blind, placebo controlled,

New, detailed results from part one of the Phase 2 portion of AbbVie’s Phase 2/3 open-label study, TURQUOISE-I, showed that patients co-infected with genotype 1 (GT1) HCV and

Specifically, in a presentation at the American Association for the Study of Liver Diseases (AASLD) meeting, the company announced it has added ALN-HDV, an RNAi therapeutic targeting the